Caricamento...

Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease

BACKGROUND: Continuous erythropoiesis receptor activator (CERA) is a newer, longer acting ESA which might be preferred to other ESAs (epoetin or darbepoetin) based on its lower frequency of administration. Different dosing requirements and molecular characteristics of CERA compared with other ESAs m...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cochrane Database Syst Rev
Autori principali: Saglimbene, Valeria M, Palmer, Suetonia C, Ruospo, Marinella, Natale, Patrizia, Craig, Jonathan C, Strippoli, Giovanni FM
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Ltd 2017
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6483666/
https://ncbi.nlm.nih.gov/pubmed/28782299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009904.pub2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !